Sentinel Node Biopsy Market Size, Share & Trends Report

Sentinel Node Biopsy Market Size, Share & Trends Analysis Report By Product (Surgical Instruments, Imaging Agents, Diagnostic Kits), By Application (Breast Cancer), By Procedure, By End Use (Hospitals & Clinics, Others), By Region And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-479-6
Number of Report Pages: 111
Format: PDF, Horizon Databook

Historical Range: 2018 - 2023
Forecast Period: 2024 - 2030
Industry: Healthcare

Market Segmentation

Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Surgical Instruments:
  - Needles
  - Probes
  - Others
- Imaging Agents
  - Radioactive Tracers
  - Fluorescent Dyes
  - Contrast Agents
- Diagnostic Kits
  - Equipment
  - Reagents
Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Breast Cancer
- Colon Cancer
- Esophageal Cancer
- Others
Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
- Open Surgery
- Minimally Invasive Surgery
Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Diagnostic Centers
Sentinel Node Biopsy Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - North America Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - North America Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - North America Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - U.S.
    - U.S. Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - U.S. Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - U.S. Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - U.S. Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Canada
    - Canada Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Canada Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Canada Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Canada Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- Europe
  - Europe Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - Europe Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - Europe Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - Europe Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - UK
    - UK Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - UK Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - UK Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - UK Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Germany
    - Germany Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Germany Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Germany Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Germany Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Italy
    - Italy Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Italy Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Italy Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Italy Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - France
    - France Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - France Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - France Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - France Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Spain
    - Spain Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Spain Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Spain Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Spain Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Denmark
    - Denmark Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Denmark Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Denmark Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Denmark Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Sweden
    - Sweden Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Sweden Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Sweden Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Sweden Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Norway
    - Norway Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Norway Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Norway Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Norway Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- Asia Pacific
  - Asia Pacific Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - Asia Pacific Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - Asia Pacific Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - Asia Pacific Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - Japan
    - Japan Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Japan Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Japan Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Japan Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - China
    - China Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - China Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - China Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - China Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - India
    - India Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - India Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - India Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - India Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - South Korea
    - South Korea Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - South Korea Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - South Korea Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - South Korea Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Australia
    - Australia Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Australia Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Australia Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Australia Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Thailand
    - Thailand Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Thailand Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Thailand Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Thailand Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- Latin America
  - Latin America Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - Latin America Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - Latin America Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - Latin America Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - Brazil
    - Brazil Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Brazil Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Brazil Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Brazil Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Mexico
    - Mexico Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Mexico Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Mexico Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Mexico Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Argentina
    - Argentina Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Argentina Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Argentina Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Argentina Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
- MEA
  - MEA Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Surgical Instruments:
      - Needles
      - Probes
      - Others
    - Imaging Agents
      - Radioactive Tracers
      - Fluorescent Dyes
      - Contrast Agents
    - Diagnostic Kits
      - Equipment
      - Reagents
  - MEA Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Breast Cancer
    - Colon Cancer
    - Esophageal Cancer
    - Others
  - MEA Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
    - Open Surgery
    - Minimally Invasive Surgery
  - MEA Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Hospitals & Clinics
    - Ambulatory Surgery Centers
    - Diagnostic Centers
  - South Africa
    - South Africa Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - South Africa Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - South Africa Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - South Africa Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Saudi Arabia
    - Saudi Arabia Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Saudi Arabia Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Saudi Arabia Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Saudi Arabia Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - UAE
    - UAE Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - UAE Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - UAE Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - UAE Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers
  - Kuwait
    - Kuwait Sentinel Node Biopsy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Surgical Instruments:
        
        Needles
        
        Probes
        
        Others
      - Imaging Agents
        
        Radioactive Tracers
        
        Fluorescent Dyes
        
        Contrast Agents
      - Diagnostic Kits
        
        Equipment
        
        Reagents
    - Kuwait Sentinel Node Biopsy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Breast Cancer
      - Colon Cancer
      - Esophageal Cancer
      - Others
    - Kuwait Sentinel Node Biopsy Procedure Outlook (Revenue, USD Million, 2018 - 2030)
      - Open Surgery
      - Minimally Invasive Surgery
    - Kuwait Sentinel Node Biopsy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Hospitals & Clinics
      - Ambulatory Surgery Centers
      - Diagnostic Centers

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.